Depression and atherosclerosis

V G Saleptsis1, N Labropoulos, A Halaris

  • 1Department of Vascular Surgery, University Hospital of Larissa, University of Thessaly, Greece. billsaleptsis2001@yahoo.gr

Insights

Depression is linked to atherosclerosis, but more research is needed to understand this connection. Future studies should investigate the long-term effects of depression on cardiovascular health.

Area of Science:

  • Cardiovascular Epidemiology
  • Psychiatric Epidemiology

Background:

  • Depression is a common mental health condition.
  • Atherosclerosis is a leading cause of cardiovascular disease.
  • The relationship between depression and atherosclerosis is complex and not fully understood.

Purpose of the Study:

  • To systematically review the existing literature on the interaction between depression and atherosclerosis.
  • To analyze the evidence for depression's role in the development of atherosclerosis.
  • To identify gaps in current research.

Main Methods:

  • A comprehensive literature search of Medline (1966-2009) and manual searches of bibliographies.
  • Analysis of studies categorized by vascular bed.
  • Review of etiological and pathogenetic mechanisms.

Main Results:

  • Depression is often diagnosed before clinical signs of atherosclerosis appear.
  • Potential mechanisms linking depression to atherosclerosis include reduced physical activity.
  • Existing research shows an association, but the strength and causality require further investigation.

Conclusions:

  • There is an established association between depression and atherosclerosis.
  • The precise contribution of depression to atherosclerosis pathogenesis needs more research.
  • Prospective studies are essential to elucidate the long-term effects of their interaction.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...